医薬品ロジスティクス市場：輸送手段、製品、輸送、医薬品供給段階別-2025-2030年の世界予測

医薬品ロジスティクス市場の2023年の市場規模は696億8,000万米ドルで、2024年には731億2,000万米ドルに達すると予測され、CAGR 5.28%で成長し、2030年には999億4,000万米ドルに達すると予測されています。

医薬品ロジスティクス市場の範囲には、安全かつ効率的な配送を確保するために、様々なチャネルにおける医薬品の輸送、倉庫保管、管理が含まれます。医薬品はデリケートな性質を持っており、有効性と安全性を維持するために、管理された環境、正確な取り扱い、タイムリーな輸送が必要とされることが多いため、この分野は極めて重要です。その必要性は、厳格な規制基準を遵守し、温度逸脱のリスクを管理し、患者の健康転帰に不可欠な迅速な配送を確保する必要性から生じる。アプリケーションは、サプライチェーンの最適化、ラストマイル配送の強化、リアルタイム追跡のためのIoTのような技術の統合など多岐にわたる。最終用途には主にメーカー、流通業者、ヘルスケアプロバイダーが含まれ、それぞれが複雑化する流通と患者のニーズに対応するためにロジスティクスの改善を求めています。

市場促進要因として、生物製剤の普及拡大、温度に敏感な製品によるコールドチェーンロジスティクス需要の増加、追跡・自動化技術の進歩などが挙げられます。発展途上地域における製薬産業の拡大からビジネスチャンスが生まれつつあり、効率的なロジスティクス・ネットワークの整備が必要となっています。企業は、最先端の追跡ソリューションに投資し、コールドチェーン・ロジスティクスの枠組みを最適化することで、これらを活用することができます。しかし、技術統合に伴う高いコストや、求められる厳しい規制遵守の維持など、限界もあります。さらに、地政学的状況によるサプライチェーンの多様化や、ロジスティクス業務におけるサイバーセキュリティの確保が課題となっています。

イノベーションの機会は、より持続可能で効率的なコールドチェーンとラストマイル配送ソリューションの開発、サプライチェーン管理における予測分析のためのAIの活用、データ・プライバシー・プロトコルの強化にあります。企業は、高度なロジスティクス・ソリューションを取り入れるためにハイテク企業との戦略的パートナーシップに注力し、配送時間を最短化するためにドローンなどの代替輸送手段を模索すべきです。市場は、技術の進歩と規制状況の変化により、ダイナミックで競争的な様相を呈しており、持続的な事業成長のためには、絶え間ない適応と積極的な戦略立案が求められます。

市場力学：急速に進化する医薬品ロジスティクス市場の主要市場インサイトを公開

医薬品ロジスティクス市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的意思決定、新たなビジネスチャンスの獲得を行うことができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 温度管理されたロジスティクスに対する需要の高まり
  • 医薬品物流プロセスのアウトソーシングに対する潜在的ニーズ
  • ワクチンと医薬品に対する世界の需要の増加
• 市場抑制要因
  • 複雑なプロセスと非効率な製品ラベリングに関する懸念
• 市場機会
  • 医薬品ロジスティクスにおける先端技術の統合
  • 製薬産業の継続的な投資と拡大
• 市場の課題
  • 医薬品ロジスティクスに対する政府の厳しい規制

ポーターの5つの力：医薬品ロジスティクス市場をナビゲートする戦略ツール

ポーターの5つの力フレームワークは、医薬品ロジスティクス市場の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：医薬品ロジスティクス市場における外部からの影響の把握

外部マクロ環境要因は、医薬品ロジスティクス市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析医薬品ロジスティクス市場における競合情勢の把握

医薬品ロジスティクス市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス医薬品ロジスティクス市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、医薬品ロジスティクス市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限はベンダーを明確かつ正確に区分し、ユーザーが戦略目標に最適なパートナーやソリューションを特定するのに役立ちます。

本レポートは、主要な注目分野を網羅した包括的な市場分析を提供しています：

1.市場の浸透度：業界主要企業の広範なデータを含む、現在の市場環境の詳細なレビュー。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 温度管理物流の需要増加
    • 医薬品物流プロセスのアウトソーシングの潜在的ニーズ
    • ワクチンと医薬品の世界の需要増加
  • 抑制要因
    • 複雑なプロセスと非効率的な製品ラベル作成に関する懸念
  • 機会
    • 医薬品ロジスティクスにおける先進技術の統合
    • 製薬業界の継続的な投資と拡大
  • 課題
    • 医薬品ロジスティクスに関する厳格な政府規制
• 市場セグメンテーション分析
  • 輸送手段：安全管理と信頼性の向上により、航空輸送と海上輸送が好まれる傾向が高まっています。
  • 医薬品供給段階：大企業および中小企業のニーズに応じて、在庫管理のための社内および外部管理の活用
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境
• 顧客のカスタマイズ
  • バリューチェーン分析

第6章 医薬品ロジスティクス市場：交通手段別

• 航空輸送
• 鉄道輸送
• 陸上輸送
• 海上輸送

第7章 医薬品ロジスティクス市場：製品別

• 生物学的製剤およびバイオシミラー
• ブランド医薬品
• ジェネリック医薬品

第8章 医薬品ロジスティクス市場交通機関

• コールドチェーン輸送
• 非コールドチェーン輸送

第9章 医薬品ロジスティクス市場医薬品供給段階別

• 社内
• アウトソーシング

第10章 南北アメリカの医薬品ロジスティクス市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第11章 アジア太平洋地域の医薬品ロジスティクス市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第12章 欧州・中東・アフリカの医薬品ロジスティクス市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第13章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
  • ワールド・クウリアー、米国に新たな輸送拠点を3つ開設
  • スカイセルとデルタ・カーゴが戦略的パートナーシップを締結
  • Pharma.Aero、医薬品サプライチェーンの改善プロジェクトを開始

企業一覧

• DSV A/S
• A.P. Moller-Maersk A/S
• YUSEN LOGISTICS CO., LTD.
• DHL International GmbH by Deutsche Post AG
• AmerisourceBergen Corporation
• Nippon Express Co., Ltd.
• Lineage, Inc.
• ICON PLC
• Lonza Group Ltd.
• C.H. Robinson Worldwide, Inc.
• Parexel International Corporation
• Almac Group
• United Parcel Service of America, Inc.
• Clinigen Group PLC
• AIT Worldwide Logistics, Inc.
• FedEx Corporation
• Crown LSP Group
• NextPharma Logistics GmbH
• Kuehne+Nagel International AG
• Thermo Fisher Scientific, Inc.
• Kerry Logistics Network Limited
• Air Canada
• Bilcare Limited
• Infosys Limited
• Movianto Group
• AWL India Private Limited
• Catalent, Inc.
• SEKO Logistics
• SF Express Co., Ltd.
• CEVA Logistics

LIST OF FIGURES

• FIGURE 1. PHARMACEUTICAL LOGISTICS MARKET RESEARCH PROCESS
• FIGURE 2. PHARMACEUTICAL LOGISTICS MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORTATION, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORTATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TRANSPORT, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TRANSPORT, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY DRUG SUPPLY STAGE, 2023 VS 2030 (%)
• FIGURE 13. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY DRUG SUPPLY STAGE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. AMERICAS PHARMACEUTICAL LOGISTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 15. AMERICAS PHARMACEUTICAL LOGISTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. UNITED STATES PHARMACEUTICAL LOGISTICS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 17. UNITED STATES PHARMACEUTICAL LOGISTICS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. ASIA-PACIFIC PHARMACEUTICAL LOGISTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. ASIA-PACIFIC PHARMACEUTICAL LOGISTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL LOGISTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 21. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL LOGISTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 22. PHARMACEUTICAL LOGISTICS MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 23. PHARMACEUTICAL LOGISTICS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. PHARMACEUTICAL LOGISTICS MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. PHARMACEUTICAL LOGISTICS MARKET DYNAMICS
• TABLE 7. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORTATION, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY AIR SHIPPING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY RAIL SHIPPING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY ROAD SHIPPING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY SEA SHIPPING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY BIOLOGIC & BIOSIMILAR, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY BRANDED DRUGS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY GENERIC DRUGS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TRANSPORT, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY COLD-CHAIN TRANSPORT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY NON COLD-CHAIN TRANSPORT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY DRUG SUPPLY STAGE, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY IN-HOUSE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY OUTSOURCED, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. AMERICAS PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORTATION, 2018-2030 (USD MILLION)
• TABLE 23. AMERICAS PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 24. AMERICAS PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TRANSPORT, 2018-2030 (USD MILLION)
• TABLE 25. AMERICAS PHARMACEUTICAL LOGISTICS MARKET SIZE, BY DRUG SUPPLY STAGE, 2018-2030 (USD MILLION)
• TABLE 26. AMERICAS PHARMACEUTICAL LOGISTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 27. ARGENTINA PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORTATION, 2018-2030 (USD MILLION)
• TABLE 28. ARGENTINA PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 29. ARGENTINA PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TRANSPORT, 2018-2030 (USD MILLION)
• TABLE 30. ARGENTINA PHARMACEUTICAL LOGISTICS MARKET SIZE, BY DRUG SUPPLY STAGE, 2018-2030 (USD MILLION)
• TABLE 31. BRAZIL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORTATION, 2018-2030 (USD MILLION)
• TABLE 32. BRAZIL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 33. BRAZIL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TRANSPORT, 2018-2030 (USD MILLION)
• TABLE 34. BRAZIL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY DRUG SUPPLY STAGE, 2018-2030 (USD MILLION)
• TABLE 35. CANADA PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORTATION, 2018-2030 (USD MILLION)
• TABLE 36. CANADA PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 37. CANADA PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TRANSPORT, 2018-2030 (USD MILLION)
• TABLE 38. CANADA PHARMACEUTICAL LOGISTICS MARKET SIZE, BY DRUG SUPPLY STAGE, 2018-2030 (USD MILLION)
• TABLE 39. MEXICO PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORTATION, 2018-2030 (USD MILLION)
• TABLE 40. MEXICO PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 41. MEXICO PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TRANSPORT, 2018-2030 (USD MILLION)
• TABLE 42. MEXICO PHARMACEUTICAL LOGISTICS MARKET SIZE, BY DRUG SUPPLY STAGE, 2018-2030 (USD MILLION)
• TABLE 43. UNITED STATES PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORTATION, 2018-2030 (USD MILLION)
• TABLE 44. UNITED STATES PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 45. UNITED STATES PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TRANSPORT, 2018-2030 (USD MILLION)
• TABLE 46. UNITED STATES PHARMACEUTICAL LOGISTICS MARKET SIZE, BY DRUG SUPPLY STAGE, 2018-2030 (USD MILLION)
• TABLE 47. UNITED STATES PHARMACEUTICAL LOGISTICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 48. ASIA-PACIFIC PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORTATION, 2018-2030 (USD MILLION)
• TABLE 49. ASIA-PACIFIC PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 50. ASIA-PACIFIC PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TRANSPORT, 2018-2030 (USD MILLION)
• TABLE 51. ASIA-PACIFIC PHARMACEUTICAL LOGISTICS MARKET SIZE, BY DRUG SUPPLY STAGE, 2018-2030 (USD MILLION)
• TABLE 52. ASIA-PACIFIC PHARMACEUTICAL LOGISTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 53. AUSTRALIA PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORTATION, 2018-2030 (USD MILLION)
• TABLE 54. AUSTRALIA PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 55. AUSTRALIA PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TRANSPORT, 2018-2030 (USD MILLION)
• TABLE 56. AUSTRALIA PHARMACEUTICAL LOGISTICS MARKET SIZE, BY DRUG SUPPLY STAGE, 2018-2030 (USD MILLION)
• TABLE 57. CHINA PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORTATION, 2018-2030 (USD MILLION)
• TABLE 58. CHINA PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 59. CHINA PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TRANSPORT, 2018-2030 (USD MILLION)
• TABLE 60. CHINA PHARMACEUTICAL LOGISTICS MARKET SIZE, BY DRUG SUPPLY STAGE, 2018-2030 (USD MILLION)
• TABLE 61. INDIA PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORTATION, 2018-2030 (USD MILLION)
• TABLE 62. INDIA PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 63. INDIA PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TRANSPORT, 2018-2030 (USD MILLION)
• TABLE 64. INDIA PHARMACEUTICAL LOGISTICS MARKET SIZE, BY DRUG SUPPLY STAGE, 2018-2030 (USD MILLION)
• TABLE 65. INDONESIA PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORTATION, 2018-2030 (USD MILLION)
• TABLE 66. INDONESIA PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 67. INDONESIA PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TRANSPORT, 2018-2030 (USD MILLION)
• TABLE 68. INDONESIA PHARMACEUTICAL LOGISTICS MARKET SIZE, BY DRUG SUPPLY STAGE, 2018-2030 (USD MILLION)
• TABLE 69. JAPAN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORTATION, 2018-2030 (USD MILLION)
• TABLE 70. JAPAN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 71. JAPAN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TRANSPORT, 2018-2030 (USD MILLION)
• TABLE 72. JAPAN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY DRUG SUPPLY STAGE, 2018-2030 (USD MILLION)
• TABLE 73. MALAYSIA PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORTATION, 2018-2030 (USD MILLION)
• TABLE 74. MALAYSIA PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 75. MALAYSIA PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TRANSPORT, 2018-2030 (USD MILLION)
• TABLE 76. MALAYSIA PHARMACEUTICAL LOGISTICS MARKET SIZE, BY DRUG SUPPLY STAGE, 2018-2030 (USD MILLION)
• TABLE 77. PHILIPPINES PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORTATION, 2018-2030 (USD MILLION)
• TABLE 78. PHILIPPINES PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 79. PHILIPPINES PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TRANSPORT, 2018-2030 (USD MILLION)
• TABLE 80. PHILIPPINES PHARMACEUTICAL LOGISTICS MARKET SIZE, BY DRUG SUPPLY STAGE, 2018-2030 (USD MILLION)
• TABLE 81. SINGAPORE PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORTATION, 2018-2030 (USD MILLION)
• TABLE 82. SINGAPORE PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 83. SINGAPORE PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TRANSPORT, 2018-2030 (USD MILLION)
• TABLE 84. SINGAPORE PHARMACEUTICAL LOGISTICS MARKET SIZE, BY DRUG SUPPLY STAGE, 2018-2030 (USD MILLION)
• TABLE 85. SOUTH KOREA PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORTATION, 2018-2030 (USD MILLION)
• TABLE 86. SOUTH KOREA PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 87. SOUTH KOREA PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TRANSPORT, 2018-2030 (USD MILLION)
• TABLE 88. SOUTH KOREA PHARMACEUTICAL LOGISTICS MARKET SIZE, BY DRUG SUPPLY STAGE, 2018-2030 (USD MILLION)
• TABLE 89. TAIWAN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORTATION, 2018-2030 (USD MILLION)
• TABLE 90. TAIWAN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 91. TAIWAN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TRANSPORT, 2018-2030 (USD MILLION)
• TABLE 92. TAIWAN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY DRUG SUPPLY STAGE, 2018-2030 (USD MILLION)
• TABLE 93. THAILAND PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORTATION, 2018-2030 (USD MILLION)
• TABLE 94. THAILAND PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 95. THAILAND PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TRANSPORT, 2018-2030 (USD MILLION)
• TABLE 96. THAILAND PHARMACEUTICAL LOGISTICS MARKET SIZE, BY DRUG SUPPLY STAGE, 2018-2030 (USD MILLION)
• TABLE 97. VIETNAM PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORTATION, 2018-2030 (USD MILLION)
• TABLE 98. VIETNAM PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 99. VIETNAM PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TRANSPORT, 2018-2030 (USD MILLION)
• TABLE 100. VIETNAM PHARMACEUTICAL LOGISTICS MARKET SIZE, BY DRUG SUPPLY STAGE, 2018-2030 (USD MILLION)
• TABLE 101. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORTATION, 2018-2030 (USD MILLION)
• TABLE 102. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 103. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TRANSPORT, 2018-2030 (USD MILLION)
• TABLE 104. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL LOGISTICS MARKET SIZE, BY DRUG SUPPLY STAGE, 2018-2030 (USD MILLION)
• TABLE 105. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL LOGISTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 106. DENMARK PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORTATION, 2018-2030 (USD MILLION)
• TABLE 107. DENMARK PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 108. DENMARK PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TRANSPORT, 2018-2030 (USD MILLION)
• TABLE 109. DENMARK PHARMACEUTICAL LOGISTICS MARKET SIZE, BY DRUG SUPPLY STAGE, 2018-2030 (USD MILLION)
• TABLE 110. EGYPT PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORTATION, 2018-2030 (USD MILLION)
• TABLE 111. EGYPT PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 112. EGYPT PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TRANSPORT, 2018-2030 (USD MILLION)
• TABLE 113. EGYPT PHARMACEUTICAL LOGISTICS MARKET SIZE, BY DRUG SUPPLY STAGE, 2018-2030 (USD MILLION)
• TABLE 114. FINLAND PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORTATION, 2018-2030 (USD MILLION)
• TABLE 115. FINLAND PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 116. FINLAND PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TRANSPORT, 2018-2030 (USD MILLION)
• TABLE 117. FINLAND PHARMACEUTICAL LOGISTICS MARKET SIZE, BY DRUG SUPPLY STAGE, 2018-2030 (USD MILLION)
• TABLE 118. FRANCE PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORTATION, 2018-2030 (USD MILLION)
• TABLE 119. FRANCE PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 120. FRANCE PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TRANSPORT, 2018-2030 (USD MILLION)
• TABLE 121. FRANCE PHARMACEUTICAL LOGISTICS MARKET SIZE, BY DRUG SUPPLY STAGE, 2018-2030 (USD MILLION)
• TABLE 122. GERMANY PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORTATION, 2018-2030 (USD MILLION)
• TABLE 123. GERMANY PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 124. GERMANY PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TRANSPORT, 2018-2030 (USD MILLION)
• TABLE 125. GERMANY PHARMACEUTICAL LOGISTICS MARKET SIZE, BY DRUG SUPPLY STAGE, 2018-2030 (USD MILLION)
• TABLE 126. ISRAEL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORTATION, 2018-2030 (USD MILLION)
• TABLE 127. ISRAEL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 128. ISRAEL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TRANSPORT, 2018-2030 (USD MILLION)
• TABLE 129. ISRAEL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY DRUG SUPPLY STAGE, 2018-2030 (USD MILLION)
• TABLE 130. ITALY PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORTATION, 2018-2030 (USD MILLION)
• TABLE 131. ITALY PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 132. ITALY PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TRANSPORT, 2018-2030 (USD MILLION)
• TABLE 133. ITALY PHARMACEUTICAL LOGISTICS MARKET SIZE, BY DRUG SUPPLY STAGE, 2018-2030 (USD MILLION)
• TABLE 134. NETHERLANDS PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORTATION, 2018-2030 (USD MILLION)
• TABLE 135. NETHERLANDS PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 136. NETHERLANDS PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TRANSPORT, 2018-2030 (USD MILLION)
• TABLE 137. NETHERLANDS PHARMACEUTICAL LOGISTICS MARKET SIZE, BY DRUG SUPPLY STAGE, 2018-2030 (USD MILLION)
• TABLE 138. NIGERIA PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORTATION, 2018-2030 (USD MILLION)
• TABLE 139. NIGERIA PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 140. NIGERIA PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TRANSPORT, 2018-2030 (USD MILLION)
• TABLE 141. NIGERIA PHARMACEUTICAL LOGISTICS MARKET SIZE, BY DRUG SUPPLY STAGE, 2018-2030 (USD MILLION)
• TABLE 142. NORWAY PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORTATION, 2018-2030 (USD MILLION)
• TABLE 143. NORWAY PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 144. NORWAY PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TRANSPORT, 2018-2030 (USD MILLION)
• TABLE 145. NORWAY PHARMACEUTICAL LOGISTICS MARKET SIZE, BY DRUG SUPPLY STAGE, 2018-2030 (USD MILLION)
• TABLE 146. POLAND PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORTATION, 2018-2030 (USD MILLION)
• TABLE 147. POLAND PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 148. POLAND PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TRANSPORT, 2018-2030 (USD MILLION)
• TABLE 149. POLAND PHARMACEUTICAL LOGISTICS MARKET SIZE, BY DRUG SUPPLY STAGE, 2018-2030 (USD MILLION)
• TABLE 150. QATAR PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORTATION, 2018-2030 (USD MILLION)
• TABLE 151. QATAR PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 152. QATAR PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TRANSPORT, 2018-2030 (USD MILLION)
• TABLE 153. QATAR PHARMACEUTICAL LOGISTICS MARKET SIZE, BY DRUG SUPPLY STAGE, 2018-2030 (USD MILLION)
• TABLE 154. RUSSIA PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORTATION, 2018-2030 (USD MILLION)
• TABLE 155. RUSSIA PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 156. RUSSIA PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TRANSPORT, 2018-2030 (USD MILLION)
• TABLE 157. RUSSIA PHARMACEUTICAL LOGISTICS MARKET SIZE, BY DRUG SUPPLY STAGE, 2018-2030 (USD MILLION)
• TABLE 158. SAUDI ARABIA PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORTATION, 2018-2030 (USD MILLION)
• TABLE 159. SAUDI ARABIA PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 160. SAUDI ARABIA PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TRANSPORT, 2018-2030 (USD MILLION)
• TABLE 161. SAUDI ARABIA PHARMACEUTICAL LOGISTICS MARKET SIZE, BY DRUG SUPPLY STAGE, 2018-2030 (USD MILLION)
• TABLE 162. SOUTH AFRICA PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORTATION, 2018-2030 (USD MILLION)
• TABLE 163. SOUTH AFRICA PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 164. SOUTH AFRICA PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TRANSPORT, 2018-2030 (USD MILLION)
• TABLE 165. SOUTH AFRICA PHARMACEUTICAL LOGISTICS MARKET SIZE, BY DRUG SUPPLY STAGE, 2018-2030 (USD MILLION)
• TABLE 166. SPAIN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORTATION, 2018-2030 (USD MILLION)
• TABLE 167. SPAIN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 168. SPAIN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TRANSPORT, 2018-2030 (USD MILLION)
• TABLE 169. SPAIN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY DRUG SUPPLY STAGE, 2018-2030 (USD MILLION)
• TABLE 170. SWEDEN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORTATION, 2018-2030 (USD MILLION)
• TABLE 171. SWEDEN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 172. SWEDEN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TRANSPORT, 2018-2030 (USD MILLION)
• TABLE 173. SWEDEN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY DRUG SUPPLY STAGE, 2018-2030 (USD MILLION)
• TABLE 174. SWITZERLAND PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORTATION, 2018-2030 (USD MILLION)
• TABLE 175. SWITZERLAND PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 176. SWITZERLAND PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TRANSPORT, 2018-2030 (USD MILLION)
• TABLE 177. SWITZERLAND PHARMACEUTICAL LOGISTICS MARKET SIZE, BY DRUG SUPPLY STAGE, 2018-2030 (USD MILLION)
• TABLE 178. TURKEY PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORTATION, 2018-2030 (USD MILLION)
• TABLE 179. TURKEY PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 180. TURKEY PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TRANSPORT, 2018-2030 (USD MILLION)
• TABLE 181. TURKEY PHARMACEUTICAL LOGISTICS MARKET SIZE, BY DRUG SUPPLY STAGE, 2018-2030 (USD MILLION)
• TABLE 182. UNITED ARAB EMIRATES PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORTATION, 2018-2030 (USD MILLION)
• TABLE 183. UNITED ARAB EMIRATES PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 184. UNITED ARAB EMIRATES PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TRANSPORT, 2018-2030 (USD MILLION)
• TABLE 185. UNITED ARAB EMIRATES PHARMACEUTICAL LOGISTICS MARKET SIZE, BY DRUG SUPPLY STAGE, 2018-2030 (USD MILLION)
• TABLE 186. UNITED KINGDOM PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORTATION, 2018-2030 (USD MILLION)
• TABLE 187. UNITED KINGDOM PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 188. UNITED KINGDOM PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TRANSPORT, 2018-2030 (USD MILLION)
• TABLE 189. UNITED KINGDOM PHARMACEUTICAL LOGISTICS MARKET SIZE, BY DRUG SUPPLY STAGE, 2018-2030 (USD MILLION)
• TABLE 190. PHARMACEUTICAL LOGISTICS MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 191. PHARMACEUTICAL LOGISTICS MARKET, FPNV POSITIONING MATRIX, 2023

The Pharmaceutical Logistics Market was valued at USD 69.68 billion in 2023, expected to reach USD 73.12 billion in 2024, and is projected to grow at a CAGR of 5.28%, to USD 99.94 billion by 2030.

The scope of the Pharmaceutical Logistics market involves the transportation, warehousing, and management of pharmaceutical products across various channels to ensure their safe and efficient delivery. This sector is vital due to the sensitive nature of pharmaceuticals, which often require controlled environments, precise handling, and timely transportation to maintain efficacy and safety. Necessity arises from the need to comply with stringent regulatory standards, manage the risks of temperature excursions, and ensure the quick delivery essential for patient health outcomes. Applications span across supply chain optimization, last-mile delivery enhancements, and integration of technologies like IoT for real-time tracking. End-use primarily includes manufacturers, distributors, and healthcare providers, each demanding improved logistics to meet the rising complexity of distribution and patient needs.

Market insights reveal key growth drivers such as the increasing prevalence of biologics, rising demand for cold chain logistics due to temperature-sensitive products, and technological advancements in tracking and automation. Opportunities are emerging from the expansion of pharmaceutical industries in developing regions, which necessitate the development of efficient logistics networks. Companies can capitalize on these by investing in cutting-edge tracking solutions and optimizing their cold chain logistics frameworks. However, limitations include high costs associated with technology integration and maintaining the stringent regulatory compliance required. Additionally, challenges revolve around the diversification of supply chains due to geopolitical conditions and ensuring cybersecurity in logistics operations.

Innovation opportunities lie in developing more sustainable and efficient cold-chain and last-mile delivery solutions, leveraging AI for predictive analytics in supply chain management, and enhancing data privacy protocols. Businesses should focus on strategic partnerships with tech firms to incorporate advanced logistics solutions and explore alternative transport methods such as drones for minimizing delivery times. The market is dynamic and competitive, driven by technological advancements and shifting regulatory landscapes, demanding constant adaptation and proactive strategic planning for sustained business growth.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Pharmaceutical Logistics Market

The Pharmaceutical Logistics Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Growing Demand for the Temperature Controlled Logistics
  • Potential Need for the Outsourcing of Pharmaceutical Logistic Process
  • Increase in Global Demand for Vaccines and Drugs
• Market Restraints
  • Concerns Associated with Complex Process and Inefficient Product Labeling
• Market Opportunities
  • Integration of Advanced Technologies in Pharmaceutical Logistics
  • Ongoing Investments and Expansion of the Pharma Industry
• Market Challenges
  • Stringent Government Regulations for Pharmaceutical Logistics

Porter's Five Forces: A Strategic Tool for Navigating the Pharmaceutical Logistics Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Pharmaceutical Logistics Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Pharmaceutical Logistics Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Pharmaceutical Logistics Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Pharmaceutical Logistics Market

A detailed market share analysis in the Pharmaceutical Logistics Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Pharmaceutical Logistics Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Pharmaceutical Logistics Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Key Company Profiles

The report delves into recent significant developments in the Pharmaceutical Logistics Market, highlighting leading vendors and their innovative profiles. These include DSV A/S, A.P. Moller - Maersk A/S, YUSEN LOGISTICS CO., LTD., DHL International GmbH by Deutsche Post AG, AmerisourceBergen Corporation, Nippon Express Co., Ltd., Lineage, Inc., ICON PLC, Lonza Group Ltd., C.H. Robinson Worldwide, Inc., Parexel International Corporation, Almac Group, United Parcel Service of America, Inc., Clinigen Group PLC, AIT Worldwide Logistics, Inc., FedEx Corporation, Crown LSP Group, NextPharma Logistics GmbH, Kuehne + Nagel International AG, Thermo Fisher Scientific, Inc., Kerry Logistics Network Limited, Air Canada, Bilcare Limited, Infosys Limited, Movianto Group, AWL India Private Limited, Catalent, Inc., SEKO Logistics, SF Express Co., Ltd., and CEVA Logistics.

Market Segmentation & Coverage

This research report categorizes the Pharmaceutical Logistics Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Mode of Transportation, market is studied across Air Shipping, Rail Shipping, Road Shipping, and Sea Shipping.
• Based on Product, market is studied across Biologic & Biosimilar, Branded Drugs, and Generic Drugs.
• Based on Transport, market is studied across Cold-chain Transport and Non Cold-chain Transport.
• Based on Drug Supply Stage, market is studied across In-house and Outsourced.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Growing Demand for the Temperature Controlled Logistics
    • 5.1.1.2. Potential Need for the Outsourcing of Pharmaceutical Logistic Process
    • 5.1.1.3. Increase in Global Demand for Vaccines and Drugs
  • 5.1.2. Restraints
    • 5.1.2.1. Concerns Associated with Complex Process and Inefficient Product Labeling
  • 5.1.3. Opportunities
    • 5.1.3.1. Integration of Advanced Technologies in Pharmaceutical Logistics
    • 5.1.3.2. Ongoing Investments and Expansion of the Pharma Industry
  • 5.1.4. Challenges
    • 5.1.4.1. Stringent Government Regulations for Pharmaceutical Logistics
• 5.2. Market Segmentation Analysis
  • 5.2.1. Mode of Transportation: Growing preference for air and sea shipping due to their better safety controls and reliability
  • 5.2.2. Drug Supply Stage: Utilization of in-house and outsourced management for inventory control as per their need in large and SMEs
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental
• 5.5. Client Customization
  • 5.5.1. Value-Chain Analaysis

6. Pharmaceutical Logistics Market, by Mode of Transportation

• 6.1. Introduction
• 6.2. Air Shipping
• 6.3. Rail Shipping
• 6.4. Road Shipping
• 6.5. Sea Shipping

7. Pharmaceutical Logistics Market, by Product

• 7.1. Introduction
• 7.2. Biologic & Biosimilar
• 7.3. Branded Drugs
• 7.4. Generic Drugs

8. Pharmaceutical Logistics Market, by Transport

• 8.1. Introduction
• 8.2. Cold-chain Transport
• 8.3. Non Cold-chain Transport

9. Pharmaceutical Logistics Market, by Drug Supply Stage

• 9.1. Introduction
• 9.2. In-house
• 9.3. Outsourced

10. Americas Pharmaceutical Logistics Market

• 10.1. Introduction
• 10.2. Argentina
• 10.3. Brazil
• 10.4. Canada
• 10.5. Mexico
• 10.6. United States

11. Asia-Pacific Pharmaceutical Logistics Market

• 11.1. Introduction
• 11.2. Australia
• 11.3. China
• 11.4. India
• 11.5. Indonesia
• 11.6. Japan
• 11.7. Malaysia
• 11.8. Philippines
• 11.9. Singapore
• 11.10. South Korea
• 11.11. Taiwan
• 11.12. Thailand
• 11.13. Vietnam

12. Europe, Middle East & Africa Pharmaceutical Logistics Market

• 12.1. Introduction
• 12.2. Denmark
• 12.3. Egypt
• 12.4. Finland
• 12.5. France
• 12.6. Germany
• 12.7. Israel
• 12.8. Italy
• 12.9. Netherlands
• 12.10. Nigeria
• 12.11. Norway
• 12.12. Poland
• 12.13. Qatar
• 12.14. Russia
• 12.15. Saudi Arabia
• 12.16. South Africa
• 12.17. Spain
• 12.18. Sweden
• 12.19. Switzerland
• 12.20. Turkey
• 12.21. United Arab Emirates
• 12.22. United Kingdom

13. Competitive Landscape

• 13.1. Market Share Analysis, 2023
• 13.2. FPNV Positioning Matrix, 2023
• 13.3. Competitive Scenario Analysis
  • 13.3.1. World Courier Opens Three New US Transport Stations
  • 13.3.2. SkyCell and Delta Cargo Forge Strategic Partnership
  • 13.3.3. Pharma.Aero Launches Project to Improve Pharmaceutical Supply Chains

Companies Mentioned

• 1. DSV A/S
• 2. A.P. Moller - Maersk A/S
• 3. YUSEN LOGISTICS CO., LTD.
• 4. DHL International GmbH by Deutsche Post AG
• 5. AmerisourceBergen Corporation
• 6. Nippon Express Co., Ltd.
• 7. Lineage, Inc.
• 8. ICON PLC
• 9. Lonza Group Ltd.
• 10. C.H. Robinson Worldwide, Inc.
• 11. Parexel International Corporation
• 12. Almac Group
• 13. United Parcel Service of America, Inc.
• 14. Clinigen Group PLC
• 15. AIT Worldwide Logistics, Inc.
• 16. FedEx Corporation
• 17. Crown LSP Group
• 18. NextPharma Logistics GmbH
• 19. Kuehne + Nagel International AG
• 20. Thermo Fisher Scientific, Inc.
• 21. Kerry Logistics Network Limited
• 22. Air Canada
• 23. Bilcare Limited
• 24. Infosys Limited
• 25. Movianto Group
• 26. AWL India Private Limited
• 27. Catalent, Inc.
• 28. SEKO Logistics
• 29. SF Express Co., Ltd.
• 30. CEVA Logistics